The document provides information on yellow fever vaccination for travel. It states that vaccination is highly effective protection against yellow fever that lasts a lifetime with a single dose. It should be received at least 10 days before travel to areas where yellow fever is a risk. Some countries require proof of vaccination to enter. The vaccination is not recommended for certain groups like young children, pregnant women, and immunocompromised individuals. Side effects are usually mild. Precautions against mosquito bites are also important.
Yellow Fever is a serious viral infection that’s usually spread by a type of daytime biting mosquito known as the Aedes aegypti. It can be prevented with a vaccination.
Know more: https://www.travel-doc.com/service/yellowfever/
Yellow Fever is a serious viral infection that’s usually spread by a type of daytime biting mosquito known as the Aedes aegypti. It can be prevented with a vaccination.
Know more: https://www.travel-doc.com/service/yellowfever/
Why it's Important to Have Yellow Fever Vaccination Before Planning a TourTravelDoc™
Yellow fever mainly occurs in sub-Saharan Africa (countries to the south of the Sahara desert), South America (especially the Amazon) and in parts of the Caribbean.
Yellow fever can be fatal. About 8% of people who get yellow fever die from it.Luckily, there is a very effective vaccination for yellow fever. Some countries require proof of vaccination (a certificate) against yellow fever before they let you enter the country.
Important Tips of Yellow Fever VaccinationTravelDoc™
Yellow Fever Vaccination is a serious viral infection that’s usually spread by a type of daytime biting mosquito known as the Aedes aegypti. It can be prevented with a vaccination.
Yellow fever describes the symptoms people get when they are affected by the Yellow Fever i.e their eyes become yellow (jaundiced) and they develop a high fever.
Know more: https://www.flyingmedicine.uk/yellowfever-vaccination
Yellow Fever is a serious viral infection that’s usually spread by a type of daytime biting mosquito known as the Aedes aegypti. It can be prevented with a vaccination.
Know more: https://www.travel-doc.com/service/yellowfever/
Yellow Fever is a serious viral infection that’s usually spread by a type of daytime biting mosquito known as the Aedes aegypti. It can be prevented with a vaccination.
Know more: https://www.travel-doc.com/service/yellowfever/
Why it's Important to Have Yellow Fever Vaccination Before Planning a TourTravelDoc™
Yellow fever mainly occurs in sub-Saharan Africa (countries to the south of the Sahara desert), South America (especially the Amazon) and in parts of the Caribbean.
Yellow fever can be fatal. About 8% of people who get yellow fever die from it.Luckily, there is a very effective vaccination for yellow fever. Some countries require proof of vaccination (a certificate) against yellow fever before they let you enter the country.
Important Tips of Yellow Fever VaccinationTravelDoc™
Yellow Fever Vaccination is a serious viral infection that’s usually spread by a type of daytime biting mosquito known as the Aedes aegypti. It can be prevented with a vaccination.
Yellow fever describes the symptoms people get when they are affected by the Yellow Fever i.e their eyes become yellow (jaundiced) and they develop a high fever.
Know more: https://www.flyingmedicine.uk/yellowfever-vaccination
This vaccination schedule is What officially followed By Pakistan ,recommended by Who. Slides contain additional knowledge about precautions ,important points for Doctor and medical faculty who are involved. also Good learning for Medical students.
Yellow Fever is a serious viral infection that’s usually spread by a type of daytime biting mosquito known as the Aedes aegypti. It can be prevented with a vaccination.
Know more: https://www.travel-doc.com/service/yellowfever/
Yellow Fever is a serious viral infection that’s usually spread by a type of daytime biting mosquito known as the Aedes aegypti. It can be prevented with a vaccination.
Know more: https://www.travel-doc.com/service/yellowfever/
Yellow Fever is a serious viral infection that’s usually spread by a type of daytime biting mosquito known as the Aedes aegypti. It can be prevented with a vaccination.
Know more: https://www.travel-doc.com/service/yellowfever/
Yellow Fever is a serious viral infection that’s usually spread by a type of daytime biting mosquito known as the Aedes aegypti. It can be prevented with a vaccination.
Know more: https://www.travel-doc.com/service/yellowfever/
This vaccination schedule is What officially followed By Pakistan ,recommended by Who. Slides contain additional knowledge about precautions ,important points for Doctor and medical faculty who are involved. also Good learning for Medical students.
Yellow Fever is a serious viral infection that’s usually spread by a type of daytime biting mosquito known as the Aedes aegypti. It can be prevented with a vaccination.
Know more: https://www.travel-doc.com/service/yellowfever/
Yellow Fever is a serious viral infection that’s usually spread by a type of daytime biting mosquito known as the Aedes aegypti. It can be prevented with a vaccination.
Know more: https://www.travel-doc.com/service/yellowfever/
Yellow Fever is a serious viral infection that’s usually spread by a type of daytime biting mosquito known as the Aedes aegypti. It can be prevented with a vaccination.
Know more: https://www.travel-doc.com/service/yellowfever/
Yellow Fever is a serious viral infection that’s usually spread by a type of daytime biting mosquito known as the Aedes aegypti. It can be prevented with a vaccination.
Know more: https://www.travel-doc.com/service/yellowfever/
Yellow Fever is a serious viral infection that’s usually spread by a type of daytime biting mosquito known as the Aedes aegypti. It can be prevented with a vaccination.
Know more: https://www.travel-doc.com/service/yellowfever/
Yellow fever describes the symptoms people get when they are affected by the Yellow Fever i.e their eyes become yellow (jaundiced) and they develop a high fever. The disease is caused by a virus which is transmitted to people after they are bitten by an infected mosquito.
See more: https://www.privatemedical.clinic/yellowfever-vaccination-clinic
Travel Vaccination Clinics are very important and provide some protection. You should still take care with food, drink and personal hygiene when aborad.When you have your check-up at your local surgery, it’s a good idea to review your medical history, present state of health, medications and any allergies. Keep your immunisation certificates (and list of current medication) with your passport for use during your travels and as a record for the future.
Know more: https://www.travel-doc.com/service/vaccinations/
Our aim is very simple: To protect the health of overseas travellers by reducing the risk of problems abroad and to generally promote a safe, healthy and enjoyable travel experience.
Know more: https://www.travel-doc.com/
Children are not “mini-adults”. Each child is different from the others. Children of the same age are different from one another. Be it the pace of fine motor growth, gross motor, social or cognitive development. Childhood is a time of rapid growth and change. That’s why regular visits are important to track their growth as well as development and also Vaccination/ Immunization is also necessary for your little one. Vaccination is the most efficient way to protect children from dangerous diseases.
Dr. Chakne Hospital is the most reliable Children’s vaccination center at PCMC. It includes newborn care, Pediatric Diseases and Treatment, immunization, vaccinations, and routine health Checkups.
There are many misconceptions about the flu shot that make the rounds each year. Internal Medicine Physician, Dr. Charles Schwartz, sets the record straight.
Yellow fever is a serious viral infection that's spread by a type of daytime biting mosquito known as the Aedes Aegypti mosquito.
Know more: https://www.regentstreetclinic.co.uk/yellow-fever-vaccine-leicester/4592801740
I think this vaccine should be known for the people who are not familier for the health.
What is Vaccine.?
How many type of Influrenza flu.?
I will be happy for the knowledge....Neon Mg Mg
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
2. Luckily, there is a very effective vaccination for yellow fever. Some countries require proof of
vaccination (a certificate) against yellow fever before they let you enter the country.
Vaccination is the single most effective way of preventing yellow fever. In the UK, Stamaril
(produced by Sanofi Pasteur MSD) is the only licensed yellow fever vaccine. A single dose of
the yellow fever vaccine will protect against yellow fever for life. It is no longer
recommended to have a booster dose every 10 years (WHO, World Health Organisation, July
2016).
Ideally, you should have the yellow fever vaccination at least 10 days before your travel. This
will allow enough time for your body to develop protective antibodies against the yellow fever
infection.
3. The yellow fever vaccination is recommended for:
Anyone traveling to, or living in, areas or countries where yellow fever is endemic.
Anyone traveling to a country where an International Certificate of Vaccination or
Prophylaxis (ICVP) against yellow fever is required for entry.
You must have a yellow fever vaccination at least 10 days before you travel. This will
allow enough time for your body to develop protective antibodies against the yellow
fever infection.
4. Certificate of proof of vaccination
Under regulations set out by the World Health Organization (WHO), anyone traveling to a
country or area where the Aedes aegypti mosquito is found must have the vaccine or have an
International Certificate of Vaccination or Prophylaxis (ICVP). You can find a list of all the
countries that require you to have an ICVP in the WHO International travel and health guide.
You can also search the country information on NaTHNaC to find out whether the places you
are visiting require an ICVP.
If you have been traveling in an “at-risk” area during the past month, it is a good idea to carry
your certificate with you. This will help avoid potential problems with immigration. It is
possible for travelers without a valid yellow fever vaccination certificate to be vaccinated and
held in isolation for up to 10 days. An ICVP is not required for entry into the UK.
If you lose your certificate, you may be able to get another one reissued as long as you have
details of the vaccination batch number and the date you had the vaccination.
Always consult staff at a designated vaccination centre if you are planning to travel to an area
where there is a risk of getting yellow fever. If you tell them where you are traveling to, they
will be able to advise you about whether you need to be vaccinated against yellow fever and
whether you need an ICVP.
5. Who should not be vaccinated?
People who should not have the yellow fever vaccination include:
Babies under nine months of age – babies who are six to nine months old should only be
vaccinated if the risk of getting yellow fever during travel is unavoidable.
Pregnant women – unless the risk of yellow fever is unavoidable.
Breastfeeding women – unless the risk of yellow fever is unavoidable.
People whose immune systems are lowered (immunosuppressed) – such as people with HIV
and those receiving chemotherapy or radiotherapy.
People who are allergic to eggs – the vaccine contains small amounts of egg white protein,
albumin.
6. People who have had a severe allergic reaction (anaphylaxis) to a previous dose of the yellow
fever vaccine.
People who are allergic to any of the ingredients in the vaccine (including eggs).
People who have a condition that affects the thymus gland (part of your immune system that is
located in your upper chest).
People who are currently very unwell (such as with a high fever) – this is to avoid confusing
the diagnosis of your current illness with any side effects from the vaccine.
Yellow fever naïve travellers – those who have not been previously exposed to the vaccine
who are 60 years of age or over should be individually assessed by the travel doctor or nurse.
7. Exemption letters
In cases where having a yellow fever vaccination is not advised, your GP may be able to issue
you with an exemption letter. The letter should be written on headed notepaper and include the
practice details.
It may be accepted by some immigration authorities although this is not guaranteed. If you are
traveling from an area where there is a risk of yellow fever without a valid yellow fever
certificate, immigration officials are legally entitled to quarantine you for a period of at least
seven days at the point of arrival into a country.
8. Side effects of the vaccine
After having the yellow fever vaccine, 10-30% of people will have mild side effects
such as: headache, muscle pain, soreness at the injection site and mild fever.
Reactions at the injection site usually occur one to five days after being vaccinated,
although other side effects may last for up to two weeks.
An allergic reaction to the vaccine occurs in one case out of every 130,000 doses of the
vaccine that are given. Yellow fever vaccine-associated neurological disease (YEL-
AND).
Rarely, the yellow fever vaccine is associated with a neurological condition known as
yellow fever vaccine-associated neurological disease (YEL-AND). Neurological
means that it affects the nerves and the nervous system, including the brain and
spinal cord.
YEL-AND occurs in around four cases out of every 1 million doses given. However,
for people who are 60 years of age or over and yellow fever vaccine naïve, the
incidence of YEL-AND increases to around one in every 50,000. This needs to be
balanced against the risk of acquiring the disease.
9. Preventing mosquito bites
As well as getting the yellow fever vaccination before traveling, you should also take
steps to avoid being bitten by mosquitoes. The mosquitoes that carry yellow fever bite
during daylight hours. Although it may not always be possible, you should try to:
Avoid places where mosquitoes live, such as swamps, forests and jungles
Choose air-conditioned accommodation. Mosquitoes do not like air-conditioned
spaces.
Choose accommodation with mesh screening over the windows and doors.
Wear loose fitting, long-sleeved tops and trousers, even in the heat of day.
Use insect repellent containing DEET on exposed skin, such as Jungle Formula. 50%
DEET is sufficient.
Burn a mosquito coil or use a plug-in device that releases insecticide in your
accommodation.
Use a mosquito net where possible, especially in bedrooms that are not air-
conditioned.